To address whether CCR5 and its ligands were overexpressed at the systemic level, we analyzed an RNA-seq dataset from the peripheral blood of 50 cutaneous leishmaniasis patients and 14 healthy subjects (Fig 2A). This evidence concerns the gene CCR5 and cutaneous leishmaniasis.